Superimmunity by pan-sarbecovirus nanobodies

Superimmunity by pan-sarbecovirus nanobodies

Saved in:

Bibliographic Details
Main Authors:	Yufei Xiang, Wei Huang, Hejun Liu, Zhe Sang, Sham Nambulli, Jérome Tubiana, Kevin L. Williams, Jr., W. Paul Duprex, Dina Schneidman-Duhovny, Ian A. Wilson, Derek J. Taylor, Yi Shi
Format:	Article
Language:	English
Published:	Elsevier 2025-07-01
Series:	Cell Reports
Online Access:	http://www.sciencedirect.com/science/article/pii/S2211124725007946
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Novel Trispecific Neutralizing Antibodies With Enhanced Potency and Breadth Against Pan‐Sarbecoviruses
by: Rui Qiao, et al.
Published: (2025-05-01)

An adjuvanted chimeric spike antigen boosts lung-resident memory T-cells and induces pan-sarbecovirus protective immunity
by: Claudio Counoupas, et al.
Published: (2025-05-01)

Design, Immunogenicity and Preclinical Efficacy of the ChAdOx1.COVconsv12 Pan-Sarbecovirus T-Cell Vaccine
by: Edmund G.-T. Wee, et al.
Published: (2024-08-01)

Super broad and protective nanobodies against Sarbecoviruses including SARS-CoV-1 and the divergent SARS-CoV-2 subvariant KP.3.1.1
by: Haodi Dong, et al.
Published: (2024-11-01)

Genetic diversity of sarbecoviruses isolated from microbats in Southern Japan
by: Kosuke Okuya, et al.
Published: (2025-07-01)

Development of bivalent RBD adapted COVID-19 vaccines for broad sarbecovirus immunity
by: Laura A. Bruno, et al.
Published: (2025-05-01)

Sarbecovirus RBD indels and specific residues dictating multi-species ACE2 adaptiveness
by: Jun-Yu Si, et al.
Published: (2024-10-01)

Broadening sarbecovirus neutralization with bispecific antibodies combining distinct conserved targets on the receptor binding domain
by: Denise Guerra, et al.
Published: (2024-12-01)

Author Correction: Sarbecovirus RBD indels and specific residues dictating multi-species ACE2 adaptiveness
by: Jun-Yu Si, et al.
Published: (2025-07-01)

Modulating ion channels with nanobodies
by: Sher Ali, et al.
Published: (2025-06-01)

Delineating the functional activity of antibodies with cross-reactivity to SARS-CoV-2, SARS-CoV-1 and related sarbecoviruses.
by: Felicitas Ruiz, et al.
Published: (2024-10-01)

Structure-guided bispecific antibody engineering confers broad protection against KP.3.1.1 and sarbecoviruses
by: Yunping Ma, et al.
Published: (2025-08-01)

Potent and broadly neutralizing antibodies against sarbecoviruses elicited by single ancestral SARS-CoV-2 infection
by: Lei Yu, et al.
Published: (2025-03-01)

The potential role of nanobodies in asthma therapy
by: Baraa Khalid Salah Al-Sheakly, et al.
Published: (2025-01-01)

NANOBODIES: STRUCTURE, MANUFACTURING, APPLICATION (REVIEW)
by: A. V. Shatalova, et al.
Published: (2019-02-01)

Nanobodies targeting the tumor microenvironment and their formulation as nanomedicines
by: Liudmyla Maksymova, et al.
Published: (2025-03-01)

ASC nanobodies to counteract the consequences of inflammasome activation
by: Sahil Adriouch, et al.
Published: (2022-05-01)

Nanobodies and their derivatives: pioneering the future of cancer immunotherapy
by: Haixia Li, et al.
Published: (2025-06-01)

Nanobody-as versatile tool emerging in autoimmune diseases
by: Ling Wang, et al.
Published: (2024-12-01)

Nanobodies: From Discovery to AI-Driven Design
by: Haoran Zhu, et al.
Published: (2025-05-01)

A rare B cell clonotype imprinted by ancestral SARS-CoV-2 develops cross-sarbecovirus neutralization in immune recalls
by: Xixian Chen, et al.
Published: (2025-07-01)

Affinity is an important determinant of the anti-trypanosome activity of nanobodies.
by: Guy Caljon, et al.
Published: (2012-01-01)

Machine Learning-Driven Methods for Nanobody Affinity Prediction
by: Hua Feng, et al.
Published: (2024-11-01)

Nanobodies in animal infectious disease control: diagnosis and therapy
by: Jing Wang, et al.
Published: (2025-07-01)

Nanobody-thioesterase chimeras to specifically target protein palmitoylation
by: Chien-Wen Kuo, et al.
Published: (2025-02-01)

Identification of neutralizing nanobodies protecting against poxvirus infection
by: Xuehua Yang, et al.
Published: (2025-03-01)

Small but Mighty: Nanobodies in the Fight Against Infectious Diseases
by: Wenning Jiang, et al.
Published: (2025-04-01)

Optimised nanobody-based quenchbodies for enhanced protein detection
by: Jordan H. Cater, et al.
Published: (2025-06-01)

Developing nanobodies as allosteric molecular chaperones of glucocerebrosidase function
by: Thomas Dal Maso, et al.
Published: (2025-05-01)

Growth inhibition of Saccharomyces cerevisiae by SUMO-specific nanobodies
by: Pavana Suresh, et al.
Published: (2025-05-01)

ACE2-independent sarbecovirus cell entry can be supported by TMPRSS2-related enzymes and can reduce sensitivity to antibody-mediated neutralization.
by: Lu Zhang, et al.
Published: (2024-11-01)

Phage-displayed synthetic library and screening platform for nanobody discovery
by: Baolong Xia, et al.
Published: (2025-08-01)

Nanobody‐mediated complement activation to kill HIV‐infected cells
by: Maria Lange Pedersen, et al.
Published: (2023-02-01)

Enhancing substrate specificity of microbial transglutaminase for precise nanobody labeling
by: Xinglong Wang, et al.
Published: (2025-03-01)

Nanobody-Based Immunoassays for the Detection of Food Hazards—A Review
by: Wenkai Li, et al.
Published: (2025-03-01)

Advancing pancreatic cancer therapy by mesothelin-specific nanobody conjugation
by: Soyeon Yi, et al.
Published: (2025-04-01)

Discovery of Nanosota-9 as anti-Omicron nanobody therapeutic candidate.
by: Gang Ye, et al.
Published: (2024-11-01)

Nanobody engineering: computational modelling and design for biomedical and therapeutic applications
by: Nehad S. El Salamouni, et al.
Published: (2025-02-01)

EspH utilizes phosphoinositide and Rab binding domains to interact with plasma membrane infection sites and Rab GTPases*
by: Ipsita Nandi, et al.
Published: (2024-12-01)

Nanobody-mediated targeting of Plasmodium falciparum PfPIMMS43 can block malaria transmission in mosquitoes
by: Chiamaka Valerie Ukegbu, et al.
Published: (2025-04-01)